From the Department of Pediatrics (A.J.W.), Saint Louis University School of Medicine; and Department of Pediatrics (I.M., J.Z.), and Division of Infectious Diseases (K.M.P., K.B.N., M.A.O.), Department of Medicine, Washington University School of Medicine, St. Louis, MO.
Neurology. 2023 Jun 6;100(23):e2324-e2330. doi: 10.1212/WNL.0000000000207269. Epub 2023 Apr 21.
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disease associated with pathogenic variants in transforming growth factor-β signaling pathway-related genes, resulting in abnormal vascular development in various organs. Brain arteriovenous malformations (AVMs) may lead to intracranial hemorrhage, and brain abscess or ischemic stroke may result from right to left shunting via pulmonary AVMs. We aimed to investigate the risk for these severe complications in both adults and children with HHT.
We conducted a case-control study among participants aged 1-64 years in the MarketScan Commercial (2006-2019) and Multistate Medicaid Databases (2011-2019). We identified cases with HHT using () diagnosis codes ( 448.0, I78.0). Control patients without HHT coding were frequency matched 10:1 to patients with HHT by age, duration of insurance enrollment, sex, and Medicaid status. Outcomes of interest (brain abscess, stroke, and intracranial/subarachnoid hemorrhage) were identified using the appropriate diagnosis codes. We calculated incidence and standardized rates of the various outcomes and compared rate ratios (RRs) between HHT cases and controls.
A total of 5,796 patients with HHT, of whom 588 were children (age younger than 16 years), were matched with 57,960 controls. There was an increased incidence of brain abscesses in HHT cases compared with controls, with an RR of 35.6 (95% CI 15.4-82.5). No brain abscesses were recorded in children aged 15 years or younger. Hemorrhagic strokes/subarachnoid hemorrhages were more common in HHT cases, with an RR of 4.01 (95% CI 2.8-5.7) in adults and 60.2 (95% CI 7.2-500.4) in children. Ischemic strokes were also more common in cases, with an RR of 3.7 (95% CI, 3.0-4.5) in adults and 70.4 (95% CI 8.7-572.3) in children.
We observed a much higher incidence of severe CNS vascular complications in patients with HHT, particularly in children. Although a higher incidence of brain abscesses was noted in adult patients with HHT, no brain abscesses were recorded in children, a result that may be considered when surveillance recommendations for this population are revisited.
遗传性出血性毛细血管扩张症(HHT)是一种与转化生长因子-β信号通路相关基因的致病性变异相关的遗传性疾病,导致各种器官的异常血管发育。脑动静脉畸形(AVM)可导致颅内出血,而肺 AVM 引起的右向左分流可导致脑脓肿或缺血性卒中。我们旨在研究 HHT 成人和儿童发生这些严重并发症的风险。
我们在 MarketScan 商业(2006-2019 年)和多州医疗补助数据库(2011-2019 年)中进行了一项病例对照研究。我们使用 ()诊断代码(448.0,I78.0)来识别 HHT 患者。无 HHT 编码的对照患者按年龄、保险登记时间、性别和医疗补助状况与 HHT 患者 10:1 频率匹配。使用适当的 诊断代码确定感兴趣的结局(脑脓肿、卒中以及颅内/蛛网膜下腔出血)。我们计算了各种结局的发生率和标准化率,并比较了 HHT 病例和对照的率比(RR)。
共有 5796 例 HHT 患者,其中 588 例为儿童(年龄小于 16 岁),与 57960 例对照相匹配。与对照组相比,HHT 患者的脑脓肿发病率增加,RR 为 35.6(95%CI 15.4-82.5)。年龄在 15 岁或以下的儿童未记录到脑脓肿。HHT 患者的出血性卒中和蛛网膜下腔出血更为常见,RR 分别为成人 4.01(95%CI 2.8-5.7)和儿童 60.2(95%CI 7.2-500.4)。成人 HHT 患者的缺血性卒也更为常见,RR 为 3.7(95%CI,3.0-4.5),儿童为 70.4(95%CI 8.7-572.3)。
我们观察到 HHT 患者的中枢神经系统血管并发症严重程度发生率更高,尤其是儿童。尽管 HHT 成年患者的脑脓肿发病率较高,但儿童中未记录到脑脓肿,这一结果在重新考虑该人群的监测建议时可能需要考虑。